Unwanted consequences of antipsychotic drugs
-The Philadelphia Inquirer
05/31/2008- Antipsychotic drugs are often prescribed to treat agitation and other symptoms of dementia, but a new study suggests they may have unwanted consequences. More>>>

Eli Lilly STALLING on ZYPREXA Payout
-World Forum

05/02/2008 - Lilly's credibility over their continuous PR on how they are going to pay out $1.2 billion in Zyprexa damages Many claimants are being stonewalled. More>>>

Anti-Psychotic Drugs (Zyprexa) Change Metabolism

-American Psysiological Society

04/20/2008 - “Based on these findings we concluded that male rats treated with olanzapine experienced an early disruption of energy metabolism. More>>>

Lechleiter inspired by Lilly's legacy

-Indy Star

04/07/2008 - Eli Lilly and Co.'s storied history was on full display last week as Sidney Taurel, a career Lilly man, retired as chief executive and was replaced by John Lechleiter, another career Lilly man. More>>>

Eli Lilly ZYPREXA Chronicles

-Indy Star

04/06/2008 - Some fast facts on the Zyprexa controversy chronicled by a patient user. More>>>

Elli Lilly Zyprexa Rico Lawsuit

-PR-Net

04/04/2008 - Attorney General Richard Blumenthal sues Eli Lilly and Company, Inc. for illegally marketing its anti psychotic drug Zyprexa for unapproved uses, and concealing the drug's serious side effects, for more than a decade. More>>>

New Anti psychotics No Better For First Episodes

-Pharmalot

03/28/2008 - The so-called atypical's - including Abilify, Risperdal, Zyprexa, Seroquel and Geodon - have been hailed as more effective and easier to tolerate than the older and cheaper kind such as Haldol, which cause tremors and rigid muscles. But the new generation are no better at treating a first episode of schizophrenia, according to a study in The Lancet. More>>>

Eli Lilly Settling Zyprexa Lawsuit

-FDA News

03/28/2008 - Eli Lilly has agreed to pay Alaska $15 million to settle a lawsuit alleging the company made deceptive claims about Zyprexa, concealed the drug’s side effects and marketed it off-label for Medicaid recipients. More>>>

Alaska Suit Against Lilly Is Settled

-NY Times

03/27/2008 - The prospect of a pending Supreme Court case that could sweep away many lawsuits against drug companies loomed over Alaska’s decision to settle the state’s suit against Eli Lilly over the schizophrenia drug Zyprexa, lawyers for Lilly and the state said Wednesday. More>>>

Concerns About Supreme Court Case on Product Liability in State Courts Prompt Alaska To Settle Medicaid Lawsuit

-Kaiser Network

03/27/2008 - The $15 million settlement this week of a lawsuit filed by the state of Alaska against Eli Lilly over allegations that the company concealed data about the side effects of the anti psychotic Zyprexa More>>>

Lilly Settles Alaska Suit Over Zyprexa

-NY Times

03/26/2008 - Eli Lilly has agreed to pay $15 million to the state of Alaska to settle a lawsuit claiming that the company’s schizophrenia drug Zyprexa caused patients to develop diabetes, Lilly and the state said Wednesday morning. More>>>

Lilly settles Zyprexa case with Alaska for $15 mln

-Reuters

03/26/2008 - Eli Lilly and Co on Wednesday said it agreed to pay $15 million to settle a lawsuit by the state of Alaska accusing it of concealing possible side effects from Zyprexa, its widely used schizophrenia medicine. More>>>

Lilly agrees to $15 million payout to settle Alaskan Zyprexa case

-PharmaTimes

03/26/2008 - US drug giant Eli Lilly has agreed to pay the state of Alaska $15 million to settle claims that its Medicaid program was not adequately warned over potential side effects from the use of its anti psychotic Zyprexa. More>>>

Why Drug Lawsuits are Necessary: FDA “isn’t capable of policing” drug safety, says Alaska Judge

-Tort Deform

03/25/2008 - The state of Alaska is suing Eli Lilly (NYSE:LLY) for failing to disclose health risks (like diabetes and weight gain) allegedly associated with Lilly’s hugely profitable “atypical anti psychotic” drug Zyprexa. More>>>

Zyprexa: Balancing Serious Side Effects With Serious Illness

-Wall Street Journal

03/25/2008 - Lawyers for the state of Alaska have spent weeks arguing in an Anchorage courthouse that Eli Lilly hid the dangers of its anti psychotic drug Zyprexa — a claim Lilly denies. More>>>

Former Biotech CEO Indicted on Fraud Charges

-Wall Street Journal

03/19/2008 - The feds have indicted a former biotech CEO, arguing that he committed criminal acts when he promoted a drug for uses that hadn’t been approved by the FDA. More>>>

Lilly Zyprexa-Claim Losses May Climb to $1.83 a Share

-Bloomberg

03/18/2008 - An adverse jury decision in Alaska may be the first step in tripling to more than $3 billion Eli Lilly & Co.'s costs of resolving lawsuits over Zyprexa, which generates more than one-fourth of the company's revenue. More>>>

API patients on Zyprexa got diabetes, official says

-Anchorage Daily News

03/13/2008 - Patients taking the anti-psychotic drug Zyprexa needlessly developed diabetes because doctors didn't have all the information about risks, the medical director of Alaska's only public mental hospital said in court Wednesday. More>>>

Eli Lilly Denies Corrupt Practices On Zyprexa

-CNN

03/12/2008 - Eli Lilly & Co. (LLY) said it "strongly disagrees" with statements made by Connecticut Attorney General Richard Blumenthal Tuesday regarding the company's marketing of anti psychotic drug Zyprexa. More>>>

Lilly accused of "sick marketing mind set" in new Zyprexa lawsuit

-PharmaTimes

03/12/2008 - Connecticut has become the latest US state to sue Eli Lilly after claiming that the firm marketed the anti psychotic Zyprexa for unapproved off-label uses,and hid side effects such as weight gain and diabetes. More>>>

Connecticut Sues Eli Lilly Over Zyprexa

-eCanadaNow

03/12/2008 - Washington (eCanadaNow) - Connecticut has joined the list of states who have filed lawsuits against drug manufacturer Eli Lilly, over their Zyprexa drug. More>>>

Connecticut Sues Eli Lilly Over Zyprexa

-Wall Street Journal

03/11/2008 - Connecticut’s Attorney General Richard Blumenthal is suing Eli Lilly over the marketing of its anti psychotic drug Zyprexa, the AP reports. He ought to take a number — at least nine other states are suing the company for similar reasons. And federal prosecutors are also on the case, reportedly negotiating a big settlement with the company. More>>>

Anti psychotic meds may raise blood sugar
-Blog.wsj.com
03/02/2008 - Even as Eli Lilly’s lawyers are getting ready to defend a Zyprexa case in Alaska, the company’s got bad news from the FDA, four time zones away. The agency refused to approve the company’s application for a long-acting form of the anti-psychotic drug the company said this morning. More>>>>

FDA Doesn't Approve A Form of Lilly's Zyprexa
-Wall Street Journal Online
02/29/2008 - The Food and Drug Administration declined to approve a long-acting, injectable form of Eli Lilly & Co.'s top-selling drug Zyprexa, the company said. More>>>

FDA rebuffs long-acting Zyprexa

-Indianapolis Business Journal
02/28/2008 - Eli Lilly and Co. has been rejected in its attempt to win approval for a long-acting, injectible version of its best-selling drug, Zyprexa. More>>>

Drug Company 'Eli Lilly' In Advanced Settlement Talks with Federal Investigators
-Tech News
02/27/2008 - Schizophrenia is a mental illness that affects over 2 million people in the U.S. Symptoms include severely impaired thinking, emotions, and behaviors. Typically, its onset is between the ages of 16 and 25 and about $70 billion is spent each year to treat the disease. More>>>>

Eli Lilly in Shareholder Cross Hairs
-FDA News

02/11/2008 - While Eli Lilly's Zyprexa troubles with the federal government may be coming to an end, the company faces new legal problems with a recent lawsuit filed by two of the company's shareholders. More>>>>

Long-Acting Zyprexa Works, But Has Sedation Risk, FDA Says
-Wall Street Journal
02/04/2008 -The Food and Drug Administration said Monday that a long-acting, injectable form of Eli Lilly & Co.'s top-selling drug Zyprexa was effective at treating schizophrenia but caused "profound sedation" in certain patients. More>>>>

Lilly subpoenaed on Zyprexa marketing
-LA Times

01/31/2008 - Eli Lilly & Co. said Wednesday that it received a subpoena in November from a U.S. grand jury in Pennsylvania seeking documents involving the marketing of the company's best selling drug, the anti psychotic Zyprexa. More>>>>

Lilly reportedly in talks with feds Newspaper: $1B payment
-Indianapolis Star
01/31/2008 - Eli Lilly and Co. could pay more than $1 billion to settle a criminal and civil investigation into the marketing of its anti psychotic drug Zyprexa, according to The New York Times, citing anonymous sources involved in the probe. More>>>>

Lilly Is in Talks to Settle Zyprexa Allegations
-Wall Street Journal

01/31/2008 - Eli Lilly & Co. is in advanced settlement talks with federal investigators regarding the company's marketing of anti psychotic drug Zyprexa, after a grand jury subpoena late last year raised the prospect that the company could be indicted. More>>>>

Discovery Limited in Zyprexa Case

-Indianapolis Star
12/07/2004 - A federal judge has told Eli Lilly and Co. to be ready for trial within a year to defend its star drug Zyprexa against charges in federal court that the drug causes diabetes and related problems.More>>>

Lilly Adds Weapon in Zyprexa Suits

-Indianapolis Star
11/07/2004 - Eli Lilly Co. is using a new legal tactic to stall the filing of potentially hundreds of new lawsuits over its best-selling drug Zyprexa.More>>>

Lilly Acts to Counter Attack Ads

-Indianapolis Star
10/14/2004 - Eli Lilly and Co. said it is concerned that lawyers are scaring some patients from using the anti-psychotic Zyprexa by running advertisements seeking clients who feel they have been harmed by the drug.More>>>

If you or a loved one have experienced Zyprexa side effects you may be entitled to compensation. Contact the Zyprexa attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and lawyers are standing by to answer any questions you may have regarding Zyprexa side effects, a possible Zyprexa class action lawsuit, or any other type of Zyprexa litigation.